Conversion of Omega-6 to Omega-3 Fatty Acids Protects Against Liver Injury in a Murine Model

Area of Science:

• Hepatology
• Nutritional Science
• Genetics

Background:

• Parenteral nutrition (PN) is crucial for patients with intestinal malabsorption.
• Soybean oil lipid emulsions (SOLEs) in PN can cause liver injury due to high omega-6 fatty acids.
• Fat-1 mice possess an omega-3 fatty acid desaturase enzyme, converting omega-6 to anti-inflammatory omega-3 fatty acids.

Purpose of the Study:

• To investigate if fat-1 mice exhibit reduced severity of PN-induced fatty liver disease compared to wild-type mice.
• To evaluate the impact of omega-3 fatty acid conversion on PN-associated hepatosteatosis.

Main Methods:

• A 19-day murine model of PN-induced hepatosteatosis was used.
• Fat-1 and C57Bl/6J mice received identical lipid doses (4 g/kg/d) of SOLE or mixed-oil emulsion.
• Hepatosteatosis severity was assessed via histology and liver triglyceride assays.

Main Results:

• Fat-1 mice demonstrated significantly reduced histologic hepatosteatosis and lower liver triglyceride levels compared to C57Bl/6J mice.
• The omega-6 to omega-3 fatty acid ratio was lower in fat-1 mice across all experimental groups.
• PN + SOLE group in fat-1 mice showed less severe fatty liver disease than in C57Bl/6J mice.

Conclusions:

• Fat-1 mice, engineered for enhanced omega-3 production, exhibit less severe fatty liver disease in a PN-induced steatosis model.
• This suggests that modulating the omega-6/omega-3 ratio via genetic modification can mitigate PN-associated liver injury.